Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1
Otto Kauko(Åbo Akademi University), Jukka Westermarck(Åbo Akademi University)
Cited by 71
Related Papers
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
|EMBO Reports|2017|101
<i>UBR5</i> Is Coamplified with <i>MYC</i> in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
|Cancer Research|2020|56
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A
|Nature Communications|2023|34
CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection
|PLoS ONE|2016|21
RAS and PP2A activities converge on epigenetic gene regulation
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1